Intravenous miconazole therapy for experimental keratomycosis in rabbits.
Intravenous miconazole (90 mg daily for 3 weeks) reduced the intensity of experimental fungal keratitis due to Candida albicans in a group of 10 rabbits. Clinical scores of affected eyes were statistically significantly lower in the treated group than in a control group of 10 untreated rabbits. All cultures of corneal scrapings were negative on 18th day after inoculation in the treated group, but four cultures were still positive on the 21st day in the control animals. Histopathological examination of eyes from treated and untreated rabbits showed great differences in the severity of inflammatory changes in the two groups.
D000818:Animals; D002177:Candidiasis / Q000188:drug therapy* / Q000473:pathology; D003319:Corneal Stroma / Q000473:pathology; D003320:Corneal Ulcer / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D005260:Female; D007275:Injections, Intravenous; D007634:Keratitis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits
D008825:Miconazole